Taxotere Cases Designated Multicounty Litigation

Over 350 lawsuits have been filed concerning the breast cancer drug Taxotere, now part of multi-county litigation. Approved by the FDA in 1996, Taxotere was initially sold without warnings about permanent hair loss, a risk later added to its label in 2015 following lawsuits. Research indicates that 9.2% of patients experienced long-term hair loss, and 6.3% reported poor regrowth. Plaintiffs argue that Sanofi Aventis knew of these risks earlier. Support groups have emerged for affected women, and alternative drugs without this side effect are available.

MIDDLESEX, NJ- Einnews.com reports that there have been more than 350 lawsuits filed in relation to the breast cancer treatment drug Taxotere, the cases have been designated multi-county litigation. Some cases involving Taxotere had already begun at the time when the cases were merged to multicounty litigation.

 

The FDA approved Taxotere in 1996. The drug has been used since then, but it is sold without warning about the hair loss associated with this drug. While most people understand that many chemotherapy drugs cause the loss of a patient’s hair, the hair loss is considered temporary.

In 2015, the manufacturer of Taxotere, Sanofi Aventis, changed the product label to include the possibility of permanent hair loss. Court documents indicate that the company knew about the risk of permanent hair loss for years before it changed the label. A lawsuit sparked the company’s decision to add permanent hair loss to the label.

One study indicated that out of 1,060 patients who used the drug, about 9.2 percent lost their hair for a decade or more. Another 6.3 percent of women suffered from poor regrowth of their hair after taking Taxotere.

The plaintiffs also pointed to studies indicating that hair loss is a major concern for cancer patients. In fact, about 8 percent of women opt out of any form of treatment that would cause them to lose their hair.

Support groups have formed online connecting women who are now suffering from alopecia because of a side effect to Taxotere that they were not even warned of and were not able to prepare themselves for facing.

There are alternative drugs that do not carry the same risk of alopecia.

* http://www.einnews.com/pr_news/460058911/all-cases-involving-breast-cancer-drug-taxotere-designated-by-court-as-multicounty-litigation
**https://www.telegraph.co.uk/lifestyle/wellbeing/healthadvice/11841436/I-survived-cancer-but-drugs-left-me-with-permanent-alopecia.html

Free Consultation
Parker Waichman LLP
Are you inquiring about a new matter?
Please Describe the Details of Your Inquiry
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
4.8 from 549 Reviews

Client Reviews

Our law firm is ready to represent you in your injury case. We’ve helped many New York residents as well as those needing help nationwide. Contact our team for a free case consultation today.

Gerard Ryan has been there with me from day 1. HE has helped me in every way.
Gerard Swanson
8 years ago
Don't know how you can improve, I was highly satisfied with Ashley, and would definitely recommend her to anyone needing legal representation
Darlene Coughlin
4 years ago
Thank you Parker Waichman for assisting me with my case. Everyone has been extremely Professional and attentive. A special thank you to Joanne who is very Courteous with a great sense of humor and always goes the extra mile. Definitely recommend 10/10!
Nydirah Banks
4 days ago
Great attorneys
Doug Whitman
3 years ago

Contact Us Today

If you or a loved one has been injured in an accident or have been injured by another party in some other way, we are here to stand up for your rights. Our personal injury attorneys have been representing injury victims and their families in Long Island and throughout the nation since the early 1980s.